Clinical practice guideline update reports revised management strategies in type 2 diabetes, highlighting evidence from recent randomized controlled trials and meta-analyses.
The practical recommendations of the German Diabetes Society/Deutsche Diabetes Gesellschaft (DDG) together with the German Society for Internal Medicine/Deutschen Gesellschaft für Innere Medizin (DGIM) are based on the contents of the National Treatment Guideline (Nationale Versorgungsleitlinie NVL) “Therapy of Type 2 Diabetes” [ 1 ]. The modifications in therapy and their justifications made in the present DDG practical recommendations were updated on the basis of new randomized controlled trials (RCTs) and meta-analyses and were consented by the DDG and the DGIM.
No takes yet. Share an insight, caveat, or question.
Landgraf et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: